Your browser does not support JavaScript!

Esco VacciXcell News

Application And Technology News

From Race for the First, To Race against the Variants

From Race for the First, To Race against the Variants

In early 2020, several companies have worked round-the-clock to commercialize the first COVID-19 vaccine. Pfizer/BioNTech, Sinovac, ...

June 10, 2021
The Health Quarters: Esco Healthcare Quarterly Newsletter (Issue 1, May 2021)

The Health Quarters: Esco Healthcare Quarterly Newsletter (Issue 1, May 2021)

Esco Healthcare unveils the first issue of its quarterly newsletter, The Health Quarters (The HQ), featuring its esteemed project h...

May 28, 2021
Adherent & Suspension Cell Culture in Bioprocessing

Adherent & Suspension Cell Culture in Bioprocessing

Growing adherent cells in culture involves a treated surface for attachment (in monolayers or in vivo) while suspension cells are free-float...

February 1, 2021
Where We are Now in the Race for the COVID-19 Vaccine

Where We are Now in the Race for the COVID-19 Vaccine

The COVID-19 pandemic is an uncharted territory where almost all countries of the world have established the use of mouth-and-nose protectio...

September 28, 2020
The Race for the SARS-CoV-2 Vaccine

The Race for the SARS-CoV-2 Vaccine

Health authorities around the world are on high alert due to an outbreak of respiratory illness caused by a novel coronavirus that was first...

April 7, 2020
Coronaviruses: Lessons from Past Outbreaks to Aid in the Development of Tools against COVID-19

Coronaviruses: Lessons from Past Outbreaks to Aid in the Development of Tools against COVID-19

Officially named by the World Health Organization as COVID-19, the recent coronavirus disease outbreak that started in Wuhan, China remains ...

March 3, 2020
Viral in 2020: Tide Motion Platform for Viral Vector Manufacturing

Viral in 2020: Tide Motion Platform for Viral Vector Manufacturing

Viral vectors are derived from parental wild-type viruses, whose pathogenic genes are removed and replaced with gene...

January 17, 2020
Why the TideXcell<sup>™</sup> Cell Harvesting System Is a 20/20

Why the TideXcell Cell Harvesting System Is a 20/20

Cell attachment in 3-dimensional carriers is proven advantageous for adherent cell growth to mimic the in vivo

January 17, 2020